Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1055)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2694)
  2. Department of Medicine (2694)
  3. Hematologic Malignancies, Division of (2694)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (654)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (443)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (41)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2694)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A new paradigm in CLL: Minimizing toxicity by using the minimum effective dose (MED) of lenalidomide for older patients with CLL
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Maslak, P. G.; Jurcic, J. G.; Rosenblat, T. L.; Noy, A.; Palomba, M. L.; Weiss, M. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Characteristics and outcomes of extranodal NK/t-cell lymphoma (ENKL): A North American (NA) multi-institutional experience
    Meeting Abstract

    Maeda, L. S.; Geiger, J. L.; Savage, K. J.; Rose, J.; Pinter-Brown, L. C.; Lunning, M. A.; Abramson, J. S.; Bartlett, N.; Vose, J.; Drape, J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free survival for subsequent relapses in patients with peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Horwitz, S. M.; Delarue, R.; Lunning, M. A.; Vose, J.; Coiffier, B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Central nervous system involvement in T-cell lymphomas: A single center experience
    Meeting Abstract

    Gurion, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo
    Journal Article

    Prince, H. M.; Duvic, M.; Martin, A.; Sterry, W.; Assaf, C.; Straus, D. J.
    Journal of the American Academy of Dermatology (2012)

    Fulltext@MSK | Save
  • An enhanced international prognostic index (IPI) for patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era using the National Comprehensive Cancer Network (NCCN) database
    Meeting Abstract

    Zhou, Z.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Vanderplas, A.; Crosby-Thompson, A.; Zelenetz, A. D.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • A targeted mutational landscape of angioimmunoblastic T-cell lymphoma: Association between advanced age and mutations in TET2 and DNMT3A
    Meeting Abstract

    Weigert, O.; Kopp, N.; Bolla, S.; Odejide, O.; Toscano, D.; Lunning, M. A.; Teruya-Feldstein, J.; Louissaint, A.; Rodig, S. J.; Horwitz, S. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Primary breast diffuse large B cell lymphoma: A distinct clinical entity
    Meeting Abstract

    Salzberg, M. P.; Maragulia, J. C.; Press, O. W.; Habermann, T. M.; Vose, J. M.; Bast, M.; Advani, R. H.; Evens, A. M.; Islam, N.; Leonard, J. P.; more...
    Blood (2012)

    Fulltext@MSK | Save